TranSINE Therapeutics Revenue and Competitors

Cambridge,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • TranSINE Therapeutics's estimated annual revenue is currently $1.1M per year.(i)

Employee Data

    TranSINE Therapeutics's People

    NameTitleEmail/Phone
    Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
    #1
    $81.4M37540%N/AN/A
    #2
    $16.9M10922%N/AN/A
    #3
    $156.1M120-70%$145MN/A
    #4
    $2.9M37-24%$150MN/A
    #5
    $1.3M170%$459.5MN/A
    #6
    $49.2M25415%$180.7MN/A
    #7
    $7M45-2%N/AN/A
    #8
    $256.3M8409%$168.5MN/A
    #9
    $4.2M15-32%N/AN/A
    #10
    $10.1M48-9%N/AN/A
    Add Company

    What Is TranSINE Therapeutics?

    TranSINE Therapeutics, is a new, rapidly evolving biotech based in the research hub of Cambridge, UK, that is focused on the development of SINEUPsTM, a revolutionary platform technology that specifically increases the translation of target proteins in a fully plug-and-play manner. This unique and scalable platform enables TranSINE to address unmet need and build differentiated products that cannot be generated with other technologies.

    keywords:N/A

    N/A

    Total Funding

    N/A

    Number of Employees

    $1.1M

    Revenue (est)

    N/A

    Employee Growth %

    N/A

    Valuation

    N/A

    Accelerator